ID

24552

Beskrivning

Study part: Study Conclusion. A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients with Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Clinicaltrials.gov Identifier: NCT00355641. Phase: phase 3. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP, Zygara; Zygara, ZIPEREVE, ZEPREVE, Requip Depot, REQUIP, REPREVE, Modutab, ADARTREL. Study Indication : Restless Legs Syndrome. Study ID: 101468/206. Clinical Study ID: 101468/206.

Nyckelord

Versioner (1)
  1. 2017-08-05 2017-08-05 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

5 augusti 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Study Conclusion (CONC) Ropinirole Restless Legs Syndrom NCT00355641

Engelsk

Study Conclusion

1 Formulär  
  1. StudyEvent: ODM
    1. Study Conclusion
STUDY CONCLUSION
Beskrivning

STUDY CONCLUSION

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
1. Date of subject completion or date of subject withdrawal
Beskrivning

date subject withdrawal

Datatyp

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0422727
2. Was the subject withdrawn from the study?
Beskrivning

subject withdrawal

Datatyp

boolean

Alias
UMLS CUI [1]
C0422727
If Yes, select primary reason for withdrawal
Beskrivning

reason

Datatyp

text

Alias
UMLS CUI [1]
C0392360
Other, specify
Beskrivning

Other

Datatyp

text

Alias
UMLS CUI [1]
C0205394
LOG STATUS
Beskrivning

LOG STATUS

Alias
UMLS CUI-1
C1708728
UMLS CUI-2
C0449438
3. Did the subject experience any non-serious adverse events during the study?
Beskrivning

non-serious adverse events

Datatyp

boolean

Alias
UMLS CUI [1]
C1518404
4. Did the subject experience any serious adverse events during the study?
Beskrivning

serious adverse events

Datatyp

boolean

Alias
UMLS CUI [1]
C1519255
5. Were any concomitant medications taken by the subject prior to screening and/or during the study?
Beskrivning

concomitant medications

Datatyp

boolean

Alias
UMLS CUI [1]
C2347852
6. Case book ready for signature
Beskrivning

signature

Datatyp

boolean

Alias
UMLS CUI [1]
C1519316
7. Q1
Beskrivning

Q1

Datatyp

boolean

8. Q2
Beskrivning

Q2

Datatyp

text

Tillbaka till toppen

Similar models

Study Conclusion

1 Formulär
  1. StudyEvent: ODM
    1. Study Conclusion
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
STUDY CONCLUSION
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
date subject withdrawal
Item
1. Date of subject completion or date of subject withdrawal
date
C0011008 (UMLS CUI [1,1])
C0422727 (UMLS CUI [1,2])
subject withdrawal
Item
2. Was the subject withdrawn from the study?
boolean
C0422727 (UMLS CUI [1])
Item
If Yes, select primary reason for withdrawal
text
C0392360 (UMLS CUI [1])
reason
Code List
If Yes, select primary reason for withdrawal
CL Item
Adverse Event (Adverse Event)
C0877248 (UMLS CUI-1)
(Comment:en)
CL Item
Lost to follow-up (Lost to follow-up)
C1302313 (UMLS CUI-1)
(Comment:en)
CL Item
Protocol violation (Protocol violation)
C1709750 (UMLS CUI-1)
(Comment:en)
CL Item
Subject decided to withdraw from the study (Subject decided to withdraw from the study)
C2348571 (UMLS CUI-1)
(Comment:en)
CL Item
Insufficient therapeutic effect (Insufficient therapeutic effect)
C1546939 (UMLS CUI-1)
(Comment:en)
CL Item
Other (Other)
C0205394 (UMLS CUI-1)
(Comment:en)
Other
Item
Other, specify
text
C0205394 (UMLS CUI [1])
Item Group
LOG STATUS
C1708728 (UMLS CUI-1)
C0449438 (UMLS CUI-2)
non-serious adverse events
Item
3. Did the subject experience any non-serious adverse events during the study?
boolean
C1518404 (UMLS CUI [1])
serious adverse events
Item
4. Did the subject experience any serious adverse events during the study?
boolean
C1519255 (UMLS CUI [1])
concomitant medications
Item
5. Were any concomitant medications taken by the subject prior to screening and/or during the study?
boolean
C2347852 (UMLS CUI [1])
signature
Item
6. Case book ready for signature
boolean
C1519316 (UMLS CUI [1])
Q1
Item
7. Q1
boolean
Item
8. Q2
text
Q2
Code List
8. Q2
CL Item
PF_SC_LOST (PF_SC_LOST)
CL Item
PF_SC_DEATH (PF_SC_DEATH)
CL Item
PF_SC_SPONSORDECISION (PF_SC_SPONSORDECISION)
CL Item
PF_SC_PHYSICIANDECISION (PF_SC_PHYSICIANDECISION)
CL Item
PF_SC_PATIENTDECISION (PF_SC_PATIENTDECISION)
CL Item
PF_SC_AE (PF_SC_AE)
CL Item
PF_SC_ALE (PF_SC_ALE)
CL Item
PF_SC_CRITERIA (PF_SC_CRITERIA)
CL Item
PF_SC_OTHER (PF_SC_OTHER)
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial